Patent ID: 9446117
Filing Date: 2016-09-20
CPC Classification: A61K,A61P,C07K,C12N

Claim Text:
1. A safe and effective immunological composition comprising: a) a recombinant, non-naturally-occurring fusion polypeptide, comprising an NSP4, a VP4 and a VP6 porcine rotavirus C polypeptide; and b) a pharmaceutically or veterinary acceptable vehicle, diluent or excipient; wherein the composition is effective in eliciting in a porcine animal a protective immune response against a subsequent virulent rotavirus challenge; wherein the polypeptide has at least 95% sequence identity to the sequence set forth in Seq. Id. No.: 95; and wherein the NSP4 polypeptide has at least 90% identity to the sequence set forth in Seq. Id. No.: 18, the VP4 polypeptide has at least 90% identity to the sequence set forth in Seq. Id. No.: 42, and the VP4 polypeptide has at least 90% identity to the sequence set forth in Seq. Id. No.: 52.